Delivery Order SPE2DB20D3103-SPE2DB22FN5B9
- Not listed
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $25,744.57 firm-fixed-price delivery order is for the supply of Tecfidera, a prescription medication, to support military healthcare programs. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00, which serves as the primary...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $51,695.63 firm fixed-price delivery order is for the supply of TECFIDERA DR 240 MG CAPSULE UU 60S, a prescription medication. This award is associated with a larger $999,999,999 Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent company, Cencora, Inc., which serves as the primary vehicle for...
- This federal contract award, with a ceiling value of $22,801.89, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of Tecfidera, a 240 mg capsule medication, and has an ultimate completion date of October 24, 2023. The contract is a delivery order with a firm fixed-price pricing type and does not have a set-aside designation. Amerisourcebergen Drug Corp holds a significant...
- This federal contract award is a delivery order issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of TECFIDERA DR 240 MG CAPSULE UU 60S. The $8,789.23 firm fixed price contract has an ultimate completion date of October 23, 2024 and does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical through...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $39,453.82 delivery order is for the supply of TECFIDERA DR 240 MG CAPSULE UU 60S, a specialty medication, with a performance period through September 30, 2022. This award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which serves as...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $35,876.33 firm fixed-price delivery order is for the supply of Tecfidera capsules, a multiple sclerosis medication. The award is not designated under any set-aside program. Amerisourcebergen Drug Corp holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for...
- This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., a major pharmaceutical distribution company. The $49,356.08 Firm Fixed Price Delivery Order contract is for the supply of Tecfidera (dimethyl fumarate) 240 mg capsules, a specialty medication used to treat multiple sclerosis. The contract has an ultimate completion date of December 27, 2023 and is not designated as a set-aside. Amerisourcebergen holds a...
- This federal contract award is for the delivery of pharmaceutical products, specifically Tecfidera capsules, to the U.S. Department of Defense. The award, valued at $92,026.33, was made to the prime contractor Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract is a delivery order under a larger Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) Troop Support Medical, valued at up to $999,999,999 and running through November 2026....
- This federal contract award, valued at $29,675.61, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is for the delivery of 4564160541 TECFIDERA DR 240 MG CAPSULE UU 60S, a prescription medication. The contract has an ultimate completion date of April 4, 2024 and was awarded on April 3, 2024. It is a Firm Fixed Price Delivery Order contract, and there is no set-aside designation,...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The $85,680.45 firm fixed-price delivery order contract is for the provision of TECFIDERA DR 240 MG CAPSULE UU 60S, a pharmaceutical product. The contract has an ultimate completion date of July 29, 2021 and was awarded on July 28, 2021. This contract is not designated as a set-aside. Amerisourcebergen Drug Corp is a major pharmaceutical...
- SPE2DB20D3103Indefinite Delivery Contract
- SPE2DB20D3103-SPE2DB22FN5B9Delivery Order
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, for the delivery of Tecfidera 240 mg capsules. The $40,728.86 firm fixed-price delivery order does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical through November 2026. This IDC serves as the primary vehicle for Amerisourcebergen to provide a comprehensive range of pharmaceutical products and medical supplies, including specialty medications, brand-name and generic drugs, vaccines, syringes, and other critical healthcare commodities to support military and veteran healthcare programs globally. Amerisourcebergen also maintains a separate $750,000 IDC with the Department of Justice Federal Bureau of Investigation for similar medical products and prescription drugs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $40.7k | 5/2/22 |